日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART)

实体瘤中心增强消融放射治疗：单臂 II 期试验研究方案 (CBART)

期刊:Technology in Cancer Research & Treatment
影响因子:2.8
doi:10.1177/15330338251350833
Jiang, Lingong; Cao, Yangsen; Yin, Xiaolan; Yu, Chunshan; Ye, Yusheng; Zhu, Xiaofei; Zhang, Huojun
发表日期：2025
文献求助 收藏

ADJUPANC protocol: a phase III study of adjuvant chemotherapy versus chemoradiotherapy for pancreatic cancer

ADJUPAC方案：一项比较胰腺癌辅助化疗与放化疗的III期研究

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2522061
Zhu, Xiaofei; Liu, Wenyu; Jiang, Lingong; Cao, Yangsen; Ye, Yusheng; Yu, Chunshan; Yin, Xiaolan; Zhang, Huojun
胰腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Stereotactic body radiation therapy plus adoptive vNKT cell therapy for pancreatic cancer: protocol of a phase II trial

立体定向放射治疗联合过继性vNKT细胞疗法治疗胰腺癌：II期临床试验方案

期刊:Immunotherapy
影响因子:2.3
doi:10.1080/1750743X.2025.2533112
Zhu, Xiaofei; Yin, Xiaolan; Liu, Wenyu; Yu, Chunshan; Xia, Sheng; Cao, Yangsen; Jiang, Lingong; Guo, Zhenhong; Zhang, Minghui; Zhang, Huojun
肿瘤
T细胞
肿瘤免疫
细胞生物学
T细胞
胰腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Stereotactic body radiation therapy for the primary tumor and oligometastases versus the primary tumor alone in patients with metastatic pancreatic cancer

立体定向放射治疗治疗原发肿瘤和寡转移灶与仅治疗原发肿瘤治疗转移性胰腺癌患者的疗效比较

期刊:Radiation Oncology
影响因子:3.2
doi:10.1186/s13014-024-02493-8
Jiang, Lingong; Ye, Yusheng; Feng, Zhiru; Liu, Wenyu; Cao, Yangsen; Zhao, Xianzhi; Zhu, Xiaofei; Zhang, Huojun
胰腺癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial

立体定向放射治疗剂量递增联合帕博利珠单抗和曲美替尼与立体定向放射治疗剂量递增联合吉西他滨治疗局部复发性胰腺癌术后生存结局的比较：一项开放标签、随机、对照的II期试验的二次分析

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2022.101764
Zhu, Xiaofei; Liu, Wenyu; Cao, Yangsen; Ju, Xiaoping; Zhao, Xianzhi; Jiang, Lingong; Ye, Yusheng; Zhang, Huojun
胰腺癌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Dose evaluations of organs at risk and predictions of gastrointestinal toxicity after re-irradiation with stereotactic body radiation therapy for pancreatic cancer by deformable image registration

利用可变形图像配准技术评估胰腺癌立体定向放射治疗后危及器官的剂量并预测胃肠道毒性。

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.1021058
Cao, Yangsen; Zhu, Xiaofei; Yu, Chunshan; Jiang, Lingong; Sun, Yongjian; Guo, Xueling; Zhang, Huojun
胰腺癌
肿瘤
毒理研究
肿瘤免疫
发表日期：2022
文献求助 收藏

Safety and Efficacy Study of Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer: Protocol of an Open-Label, Dose-Escalation, Single-Centre Phase I/II Clinical Trial

新辅助放射激素疗法治疗寡转移性前列腺癌的安全性和有效性研究：一项开放标签、剂量递增、单中心 I/II 期临床试验方案

期刊:Cancer Control
影响因子:2.6
doi:10.1177/10732748221120462
Zhao, Xianzhi; Xiao, Yu-Tian; Yang, Yue; Ye, Yusheng; Chang, Yifan; Jiang, Lingong; Eftekhar, Md; Ren, Shancheng; Zhang, Huojun
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2022
文献求助 收藏

Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles

基于分子谱的胰腺癌辅助放疗个性化设计

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.14486
Zhu, Xiaofei; Cao, Yangsen; Ju, Xiaoping; Zhao, Xianzhi; Jiang, Lingong; Ye, Yusheng; Shen, Yuxin; Cao, Fei; Qing, Shuiwang; Zhang, Huojun
胰腺癌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China

立体定向放射治疗（SBRT）治疗前列腺癌五年疗效：中国最大规模的经验

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-021-03785-2
Zhao, Xianzhi; Ye, Yusheng; Yu, Haiyan; Jiang, Lingong; Cheng, Chao; Guo, Xueling; Ju, Xiaoping; Zhu, Xiaofei; Zhang, Huojun
肿瘤
前列腺癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study

局部晚期胰腺癌立体定向放射治疗剂量递增的失败模式和结果：一项多中心队列研究

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758835920977155
Zhu, Xiaofei; Cao, Yangsen; Su, Tingshi; Zhu, Xixu; Ju, Xiaoping; Zhao, Xianzhi; Jiang, Lingong; Ye, Yusheng; Cao, Fei; Qing, Shuiwang; Zhang, Huojun
胰腺癌
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏